Election of regional representative to RCOphth Council
Following a ballot, Mr Sajjad Mahmood has been duly elected as the new regional representative for the North West region. He will take up his post following the AGM in May and we look forward to welcoming him to Council. Mrs Amy Stone will continue as the North West representative until the AGM and we
National Data Opt-out
A national data opt-out is being introduced from 25 May 2018. Communications about the national data opt-out aim to make sure that people can make an informed choice about how their confidential patient information is used for research and planning NHS and care services. The NHS is communicating to patients, public and workforce about the national data
Changes to Local Clinical Excellence Awards
NHS Employers and the BMA have agreed changes to the Local Clinical Excellence Awards (LCEAs) Scheme. The changes, which are endorsed by the Department of Health and Social Care, state that: trusts must run LCEA rounds from 1 April 2018 from 1 April 2018 to 31 March 2021, the minimum investment ratio for new LCEA will
WCSM: Submissions invited for the 2018 Ruskell Medal and Master’s Medal.
The Worshipful Company of Spectacle Makers is now inviting submissions for these two esteemed competitions, which each year attract significant interest from UK research students and departments. The winner of each medal will receive a prize of £750 and will also be invited to the Company’s Court Luncheon at Apothecaries’ Hall on Wednesday 3rd October
IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration – (IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration, Published online: 2018-04-17; | doi:10.1038/s41433-018-0080-9)
IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration, Published online: 17 April 2018; doi:10.1038/s41433-018-0080-9 IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration